Potential Biomarkers for Diagnosing Major Depressive Disorder Patients with Suicidal Ideation

Shunjie Bai,1 Liang Fang,2,3 Jing Xie,4 Huili Bai,1 Wei Wang,5 Jian-jun Chen6 1Department of Laboratory Medicine, The First Affiliated Hospital of Chongqing Medical University, Chongqing, People’s Republic of China; 2Department of Neurology, Yongchuan Hospital of Chongqing Medical Universi...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Bai S, Fang L, Xie J, Bai H, Wang W, Chen J
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2021
Materias:	major depressive disorder suicidal ideation biomarkers Pathology RB1-214 Therapeutics. Pharmacology RM1-950
Acceso en línea:	https://doaj.org/article/d65b67ba17d34bd5a2813e008fa652e9
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:d65b67ba17d34bd5a2813e008fa652e9
record_format	dspace
spelling	oai:doaj.org-article:d65b67ba17d34bd5a2813e008fa652e92021-12-02T10:59:33ZPotential Biomarkers for Diagnosing Major Depressive Disorder Patients with Suicidal Ideation1178-7031https://doaj.org/article/d65b67ba17d34bd5a2813e008fa652e92021-02-01T00:00:00Zhttps://www.dovepress.com/potential-biomarkers-for-diagnosing-major-depressive-disorder-patients-peer-reviewed-article-JIRhttps://doaj.org/toc/1178-7031Shunjie Bai,1 Liang Fang,2,3 Jing Xie,4 Huili Bai,1 Wei Wang,5 Jian-jun Chen6 1Department of Laboratory Medicine, The First Affiliated Hospital of Chongqing Medical University, Chongqing, People’s Republic of China; 2Department of Neurology, Yongchuan Hospital of Chongqing Medical University, Chongqing, People’s Republic of China; 3Chongqing Key Laboratory of Cerebral Vascular Disease Research, Yongchuan Hospital of Chongqing Medical University, Chongqing, People’s Republic of China; 4Department of Endocrinology and Nephrology, The Fourth People’s Hospital of Chongqing, Chongqing, People’s Republic of China; 5Department of Neurology, The Affiliated Hospital of Guizhou Medical University, Guiyang, People’s Republic of China; 6Institute of Life Sciences, Chongqing Medical University, Chongqing, People’s Republic of ChinaCorrespondence: Jian-jun Chen, Email chenjianjun@cqmu.edu.cnBackground: Major depressive disorder (MDD) and suicide are two major health problems, but there are still no objective methods to diagnose MDD or suicidal ideation (SI). This study was conducted to identify potential biomarkers for diagnosing MDD patients with SI.Methods: First-episode drug-naïve MDD patients with SI and demographics-matched healthy controls (HCs) were recruited. First-episode drug-naïve MDD patients without SI were also included. The serum lipids, C-reactive protein (CRP), transferring (TRSF), homocysteine (HCY) and alpha 1-antitrypsin (AAT) in serum were detected. The univariate and multivariate statistical analyses were used to identify and validate the potential biomarkers.Results: The 86 HCs, 53 MDD patients with SI and 20 MDD patients without SI were included in this study. Four potential biomarkers were identified: AAT, TRSF, high-density lipoprotein cholesterol (HDLC), and apolipoprotein A1 (APOA1). After one month treatment, the levels of AAT and APOA1 were significantly improved. The panel consisting of these potential biomarkers had an excellent diagnostic performance, yielding an area under the ROC curve (AUC) of 0.994 and 0.990 in the training and testing set, respectively. Moreover, this panel could effectively distinguish MDD patients with SI from MDD patients without SI (AUC=0.928).Conclusion: These results showed that these potential biomarkers could facilitate the development of an objective method for diagnosing MDD patients with SI, and the decreased AAT levels in MDD patients might lead to the appearance of SI by resulting in the elevated inflammation.Keywords: major depressive disorder, suicidal ideation, biomarkersBai SFang LXie JBai HWang WChen JDove Medical Pressarticlemajor depressive disordersuicidal ideationbiomarkersPathologyRB1-214Therapeutics. PharmacologyRM1-950ENJournal of Inflammation Research, Vol Volume 14, Pp 495-503 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	major depressive disorder suicidal ideation biomarkers Pathology RB1-214 Therapeutics. Pharmacology RM1-950
spellingShingle	major depressive disorder suicidal ideation biomarkers Pathology RB1-214 Therapeutics. Pharmacology RM1-950 Bai S Fang L Xie J Bai H Wang W Chen J Potential Biomarkers for Diagnosing Major Depressive Disorder Patients with Suicidal Ideation
description	Shunjie Bai,1 Liang Fang,2,3 Jing Xie,4 Huili Bai,1 Wei Wang,5 Jian-jun Chen6 1Department of Laboratory Medicine, The First Affiliated Hospital of Chongqing Medical University, Chongqing, People’s Republic of China; 2Department of Neurology, Yongchuan Hospital of Chongqing Medical University, Chongqing, People’s Republic of China; 3Chongqing Key Laboratory of Cerebral Vascular Disease Research, Yongchuan Hospital of Chongqing Medical University, Chongqing, People’s Republic of China; 4Department of Endocrinology and Nephrology, The Fourth People’s Hospital of Chongqing, Chongqing, People’s Republic of China; 5Department of Neurology, The Affiliated Hospital of Guizhou Medical University, Guiyang, People’s Republic of China; 6Institute of Life Sciences, Chongqing Medical University, Chongqing, People’s Republic of ChinaCorrespondence: Jian-jun Chen, Email chenjianjun@cqmu.edu.cnBackground: Major depressive disorder (MDD) and suicide are two major health problems, but there are still no objective methods to diagnose MDD or suicidal ideation (SI). This study was conducted to identify potential biomarkers for diagnosing MDD patients with SI.Methods: First-episode drug-naïve MDD patients with SI and demographics-matched healthy controls (HCs) were recruited. First-episode drug-naïve MDD patients without SI were also included. The serum lipids, C-reactive protein (CRP), transferring (TRSF), homocysteine (HCY) and alpha 1-antitrypsin (AAT) in serum were detected. The univariate and multivariate statistical analyses were used to identify and validate the potential biomarkers.Results: The 86 HCs, 53 MDD patients with SI and 20 MDD patients without SI were included in this study. Four potential biomarkers were identified: AAT, TRSF, high-density lipoprotein cholesterol (HDLC), and apolipoprotein A1 (APOA1). After one month treatment, the levels of AAT and APOA1 were significantly improved. The panel consisting of these potential biomarkers had an excellent diagnostic performance, yielding an area under the ROC curve (AUC) of 0.994 and 0.990 in the training and testing set, respectively. Moreover, this panel could effectively distinguish MDD patients with SI from MDD patients without SI (AUC=0.928).Conclusion: These results showed that these potential biomarkers could facilitate the development of an objective method for diagnosing MDD patients with SI, and the decreased AAT levels in MDD patients might lead to the appearance of SI by resulting in the elevated inflammation.Keywords: major depressive disorder, suicidal ideation, biomarkers
format	article
author	Bai S Fang L Xie J Bai H Wang W Chen J
author_facet	Bai S Fang L Xie J Bai H Wang W Chen J
author_sort	Bai S
title	Potential Biomarkers for Diagnosing Major Depressive Disorder Patients with Suicidal Ideation
title_short	Potential Biomarkers for Diagnosing Major Depressive Disorder Patients with Suicidal Ideation
title_full	Potential Biomarkers for Diagnosing Major Depressive Disorder Patients with Suicidal Ideation
title_fullStr	Potential Biomarkers for Diagnosing Major Depressive Disorder Patients with Suicidal Ideation
title_full_unstemmed	Potential Biomarkers for Diagnosing Major Depressive Disorder Patients with Suicidal Ideation
title_sort	potential biomarkers for diagnosing major depressive disorder patients with suicidal ideation
publisher	Dove Medical Press
publishDate	2021
url	https://doaj.org/article/d65b67ba17d34bd5a2813e008fa652e9
work_keys_str_mv	AT bais potentialbiomarkersfordiagnosingmajordepressivedisorderpatientswithsuicidalideation AT fangl potentialbiomarkersfordiagnosingmajordepressivedisorderpatientswithsuicidalideation AT xiej potentialbiomarkersfordiagnosingmajordepressivedisorderpatientswithsuicidalideation AT baih potentialbiomarkersfordiagnosingmajordepressivedisorderpatientswithsuicidalideation AT wangw potentialbiomarkersfordiagnosingmajordepressivedisorderpatientswithsuicidalideation AT chenj potentialbiomarkersfordiagnosingmajordepressivedisorderpatientswithsuicidalideation
_version_	1718396381551394816

Potential Biomarkers for Diagnosing Major Depressive Disorder Patients with Suicidal Ideation

Ejemplares similares